Systemic alterations in plasma biomarkers levels in patients with chronic pain
Alterações nos níveis plasmáticos de biomarcadores de pacientes com dor crônica
Leticia Meda Vendrusculo-Fangel; Renan Fangel; Rita de Cássia Marqueti
Abstract
Keywords
Resumo
Palavras-chave
Referências
Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003-7.
Ferreira EA, Marques AP, Matsutani LA, Vasconcellos EG, Mendonça LL. Avaliação da dor e estresse em pacientes com fibromialgia. Rev Bras Reumatol. 2002;42(2):104-10.
De Peuter S, Van Diest I, Vansteenwegen D, Van den Bergh O, Vlaeyen JW. Understanding fear of pain in chronic pain: interoceptive fear conditioning as a novel approach. Eur J Pain. 2011;15(9):889-94.
DeVon HA, Piano MR, Rosenfeld AG, Hoppensteadt DA. The association of pain with protein inflammatory biomarkers a review of the literature. Nurs Res. 2014;63(1):51-62.
Kraychete DC, Calasans MT, Valente CM. Citocinas pró-inflamatórias e dor. Rev Bras Reumatol. 2006;46(3):199-206.
Aronoff GM. What do we know about the pathophysiology of chronic pain: Implications for treatment considerations. Med Clin North Am. 2016;100(1):31-42.
Burska A, Boissinot M, Ponchel F. Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm. 2014;2014:545493.
Koch A, Zacharowski K, Boehm O, Stevens M, Lipfert P, von Giesen HJ. Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res. 2007;56(1):32-7.
Marchi A, Vellucci R, Mameli S, Rita Piredda A, Finco G. Pain biomarkers. Clin Drug Investig. 2009;29(Suppl 1):41-6.
Vaisberg M, de Mello MT, Seelaender MC, dos Santos RV, Costa Rosa LF. Reduced maximal oxygen consumption and overproduction of proinflammatory cytokines in athletes. Neuroimmunomodulation. 2007;14(6):304-9.
Wingenfeld K, Heim C, Schmidt I, Wagner D, Meinlschmidt G, Hellhammer DH. HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psychosom Med. 2008;70(1):65-72.
Anderson RU, Sawyer T, Wise D, Morey A, Nathanson BH. Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2009;182(6):2753-8.
Behm FG, Gavin IM, Karpenko O, Lindgren V, Gaitonde S, Gashkoff PA. Unique immunologic patterns in fibromyalgia. BMC Clin Pathol. 2012;12:25.
Malhotra D, Saxena AK, Dar SA, Kumar V, Nasare N, Tripathi AK. Evaluation of cytokine levels in fibromyalgia syndrome patients and its relationship to the severity of chronic pain. J Musculoskeletal Pain. 2012;20(3):164-9.
Lundh D, Hedelin H, Jonsson K, Gifford M, Larsson D. Assessing chronic pelvic pain syndrome patients: blood plasma factors and cortisol saliva. Scand J Urol. 2013;47(6):521-8.
Koike K, Shinozaki T, Hara K, Noma N, Okada-Ogawa A, Asano M. Immune and endocrine function in patients with burning mouth syndrome. Clin J Pain. 2014;30(2):168-73.
Sturgill V, MgGee E, Menzies V. Unique cytokine signature in the plasma of patients with fibromyalgia. J Immunol Res. 2014;2014:938576.
Ciszek BP, Khan AA, Dang H, Slade GD, Smith S, Bair E. MicroRNA expression profiles differentiate chronic pain condition subtypes. Transl Res. 2015;166(6):706-20.
Nenke MA, Haylock CL, Rankin W, Inder WJ, Gagliardi L, Eldridge C. Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses: A pilot randomized, placebo-controlled trial. Psychoneuroendocrinology. 2015;56:157-67.
Bäckryd E, Ghafouri B, Larsson B, Gerdle B. Plasma pro-inflammatory markers in chronic neuropathic pain: a multivariate, comparative, cross-sectional pilot study. Scand J Pain. 2016;10:1-5.
Park JW, Chung JW. Inflammatory cytokines and sleep disturbance in patients with temporomandibular disorders. J Oral Facial Pain Headache. 2016;30(1):27-33.
de Oliveira CM, Sakata RK, Issy AM, Gerola LR, Salomão R. Cytokines and pain. Rev Bras Anestesiol. 2011;61(2):255-65.
Zhang JM, An J. Cytokines, inflammation and pain. Int Anesthesiol Clin. 2007;45(2):27-37.
Okazaki Y, Sawada T, Nagatani K, Komagata Y, Unoue T, Muto S. Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis. J Rheumatol. 2005;32(8):1440-7.
Borsook D, Becerra L, Hargreaves R. Biomarkers for chronic pain and analgesia: Part 1: the need, reality, challenges, and solutions. Discov Med. 2011;11(58):197-207.
Borsook D, Becerra L, Hargreaves R. Biomarkers for chronic pain and analgesia: Part 2: how, where, and what to look for using functional imaging. Discov Med. 2011;11(58):209-19.
Rio E, Moseley L, Purdam C, Samiric T, Kidgell D, Pearce AJ. The pain of tendinopathy: physiological or pathophysiological?. Sports Med. 2014;44(1):9-23.
Submetido em:
16/09/2018
Aceito em:
07/01/2019
Facebook
Google+
Twitter
LinkedIn
Mendeley
Email